clevercast
{"PLE04":{"id":"WdekGw","strictid":"PLE04","name":"PLE04","description":"","account_id":"2bK6rw","ts":0},"PLE05":{"id":"W9mpyj","strictid":"PLE05","name":"PLE05 Closing Ceremony + Concert","description":"","account_id":"2bK6rw","ts":1638855000},"SAT09":{"id":"VvyakX","strictid":"SAT09","name":"SAT09","description":"","account_id":"2bK6rw","ts":1638889200},"SPI07":{"id":"WwGDRw","strictid":"SPI07","name":"SPI07","description":"","account_id":"2bK6rw","ts":1638874920},"SCS14":{"id":"2avEmE","strictid":"SCS14","name":"SCS14","description":"","account_id":"2bK6rw","ts":1638874920},"SCS13":{"id":"A6nmKN","strictid":"SCS13","name":"SCS13","description":"","account_id":"2bK6rw","ts":1638874920},"KEY09":{"id":"Wlqkxg","strictid":"KEY09","name":"KEY09","description":"","account_id":"2bK6rw","ts":1638874920},"KEY06":{"id":"AGZbol","strictid":"KEY06","name":"KEY06","description":"","account_id":"2bK6rw","ts":1638873120},"KEY01":{"id":"AR1vr7","strictid":"KEY01","name":"KEY01","description":"","account_id":"2bK6rw","ts":1638871320},"PLE03":{"id":"VyOE09","strictid":"PLE03","name":"PLE03","description":"","account_id":"2bK6rw","ts":1638867600},"WEB05":{"id":"AKYxLw","strictid":"WEB05","name":"WEB05","description":"","account_id":"2bK6rw","ts":1638824520},"WEB04":{"id":"V316Xb","strictid":"WEB04","name":"WEB04","description":"","account_id":"2bK6rw","ts":1638817320},"KEY05":{"id":"WNKJlG","strictid":"KEY05","name":"KEY05","description":"","account_id":"2bK6rw","ts":1638811920},"SPI06":{"id":"VBXxdo","strictid":"SPI06","name":"SPI06","description":"","account_id":"2bK6rw","ts":0},"SCS12":{"id":"VYeD58","strictid":"SCS12","name":"SCS12","description":"","account_id":"2bK6rw","ts":1638810120},"SCS10":{"id":"VDrPkz","strictid":"SCS10","name":"SCS10","description":"","account_id":"2bK6rw","ts":1638810120},"KEY03":{"id":"W9mpEj","strictid":"KEY03","name":"KEY03","description":"","account_id":"2bK6rw","ts":1638810120},"SAT08":{"id":"VvyaNX","strictid":"SAT08","name":"SAT08","description":"","account_id":"2bK6rw","ts":0},"SAT07":{"id":"WwGD3w","strictid":"SAT07","name":"SAT07","description":"","account_id":"2bK6rw","ts":0},"SPI05":{"id":"VznBKn","strictid":"SPI05","name":"SPI05","description":"","account_id":"2bK6rw","ts":1638788520},"SCS11":{"id":"ApYQ5M","strictid":"SCS11","name":"SCS11","description":"","account_id":"2bK6rw","ts":1638788520},"SCS09":{"id":"2MnrZe","strictid":"SCS09","name":"SCS09","description":"","account_id":"2bK6rw","ts":1638788520},"SPI04":{"id":"Wlqkpg","strictid":"SPI04","name":"SPI04","description":"","account_id":"2bK6rw","ts":1638781320},"SCS08":{"id":"ALoQw5","strictid":"SCS08","name":"SCS08","description":"","account_id":"2bK6rw","ts":1638781320},"SCS07":{"id":"AGZbgl","strictid":"SCS07","name":"SCS07","description":"","account_id":"2bK6rw","ts":1638781320},"WEB03":{"id":"WokLe9","strictid":"WEB03","name":"WEB03","description":"","account_id":"2bK6rw","ts":1638738120},"SAT04":{"id":"Ak6yrj","strictid":"SAT04","name":"SAT04","description":"","account_id":"2bK6rw","ts":0},"SAT06":{"id":"WdekLm","strictid":"SAT06","name":"SAT06","description":"","account_id":"2bK6rw","ts":0},"KEY08":{"id":"WNKJwG","strictid":"KEY08","name":"KEY08","description":"","account_id":"2bK6rw","ts":1638716520},"KEY10":{"id":"2bzB4G","strictid":"KEY10","name":"KEY10","description":"","account_id":"2bK6rw","ts":0},"SCS04":{"id":"VPxn5l","strictid":"SCS04","name":"SCS04","description":"","account_id":"2bK6rw","ts":1638716520},"SCS03":{"id":"WdekLP","strictid":"SCS03","name":"SCS03","description":"","account_id":"2bK6rw","ts":1638716520},"SPI02":{"id":"21a6D6","strictid":"SPI02","name":"SPI02","description":"Societal impact of influenza and COVID-19","account_id":"2bK6rw","ts":1638702120},"KEY02":{"id":"VznBQJ","strictid":"KEY02","name":"KEY02","description":"","account_id":"2bK6rw","ts":1638702000},"SCS06":{"id":"ApYQJq","strictid":"SCS06","name":"SCS06","description":"Innate and adaptive immunity towards influenza, RSV disease and COVID-19","account_id":"2bK6rw","ts":1638702120},"SPI01":{"id":"AZzDlk","strictid":"SPI01","name":"SPI01","description":"Why influenza is a priority for policy makers","account_id":"2bK6rw","ts":1638694920},"SCS02":{"id":"Wj0kJZ","strictid":"SCS02","name":"SCS02","description":"Virus structure and replication in influenza virus, RSV and SARS-CoV-2; latest developments in influenza virus, SARS-CoV-2 and RSV molecular virology","account_id":"2bK6rw","ts":1638694920},"SCS01":{"id":"24amLe","strictid":"SCS01","name":"SCS01","description":"Epidemiology, surveillance and modelling of influenza, RSV disease and COVID-19, including virus evolution and strain selection","account_id":"2bK6rw","ts":1638694920},"WEB02":{"id":"Ak6yJr","strictid":"WEB02","name":"WEB02","description":"Childhood Influenza vaccination and treatment in a COVID-19 era","account_id":"2bK6rw","ts":1638651720},"OPN01":{"id":"WqYk9o","strictid":"OPN01","name":"OPN01","description":"Opening Ceremony\n","account_id":"2bK6rw","ts":1638637200},"KEY04":{"id":"27y68N","strictid":"KEY04","name":"KEY04","description":"COVID coagulopathy in comparison to influenza and pneumococci sepsis","account_id":"2bK6rw","ts":1638694920},"PER01":{"id":"2bzBJX","strictid":"PER01","name":"Permanent Livestream","description":"","account_id":"2bK6rw","ts":0},"SAT03":{"id":"VBXxaB","strictid":"SAT03","name":"SAT03","description":"","account_id":"2bK6rw","ts":1638630000},"SAT02":{"id":"VYeDlQ","strictid":"SAT02","name":"SAT02","description":"INFLUENZA AND COVID-19 Burden of Disease and Prospects for Vaccination","account_id":"2bK6rw","ts":1638622800},"SAT01":{"id":"VBXxPX","strictid":"SAT01","name":"SAT01 ","description":"Post-COVID lockdown era: what are we facing?","account_id":"2bK6rw","ts":1638615600},"WEB01":{"id":"VYeD8w","strictid":"WEB01","name":"WEB01","description":"Vaccination in a COVID-19 era","account_id":"2bK6rw","ts":1638644520},"SAT05":{"id":"ApYQNa","strictid":"SAT05","name":"SAT05","description":"Will be streamed by Roche, not from studio Antwerp, BE","account_id":"2bK6rw","ts":1638709200}}
clevercast items
{"LAN01":{"id":"WEBElL","strictid":"LAN01","name":"Lange testtrailer","description":"","account_id":"2bK6rw","chapters":[]},"TES01":{"id":"W9Jpob","strictid":"TES01","name":"Testtrailer","description":"Test trailer for scheduling Pseudo Live Events","account_id":"2bK6rw","chapters":[]}}
Live

Recap of of the day 4 December with Colin Russell and Ab Osterhaus

09:00 - 09:45

Live

Recap of the day 5 December with Ab Osterhaus and Marco Goeijenbier

09:00 - 09:45

Live

Recap of the day 6 December with Marco Goeijenbier and Colin Russell

09:00 - 09:45

Keynote lecture: COVID coagulopathy in comparison to influenza and pneumococci sepsis

10:00 - 10:30

Speaker 
Marco Goeijenbier

Epidemiology, surveillance and modelling of influenza, RSV disease and COVID-19, including virus evolution and strain selection

10:00 - 11:45

Chairs 
Colin Russell
Seth Zost

Virus structure and replication in influenza virus, RSV and SARS-CoV-2; latest developments in influenza virus, SARS-CoV-2 and RSV molecular virology

10:00 - 11:45

Chairs 
Ed Hutchinson
Laura Martin-Sancho

Why influenza is a priority for policy makers

10:00 - 11:45

Chair 
Roman Prymula

Lessons learned from and prospects for COVID-19 vaccination

10:00 - 11:45

Chairs 
Hanna Nohynek
Margaret Lugin

Pandemic threats from the animal world

10:00 - 11:45

Chair 
Ron Fouchier

Benefits of vaccinating healthcare workers and other risk groups

10:00 - 11:45

Chair 
Antonia Ho
Live

Plenary session dedicated to the work of Young Scientists

10:00 - 11:00

Chair 
Marco Goeijenbier

Keynote lecture: Likelihood of transmission of baloxavir-resistant influenza viruses from baloxavir-treated index patients to untreated household contacts in the BLOCKSTONE study

11:00 - 11:30

Speaker 
Aeron Hurt
Live

Poster Peek with Colin Russell

11:00 - 12:00

Keynote lecture: Human challenge studies: limitations and strenghts

11:30 - 12:00

Speaker 
Christopher Chiu
Live

Satellite Symposium organised by Janssen: Post-COVID lockdown era: what are we facing?

12:00 - 13:45

Chairs 
Stefan Scholten
Carlo Federico Perno
Live

Keynote lectures on Science based management of epidemics and pandemics

12:00 - 13:45

Speaker 
Ab Osterhaus

Innate and adaptive immunity towards influenza, RSV disease and COVID-19

12:00 - 13:45

Chair 
Guus Rimmelzwaan

Societal impact of influenza and COVID-19

12:00 - 13:45

Chair 
Terho Heikkinen
Live

Poster Peek with Marco Goeijenbier

12:00 - 13:00

Viral and host factors in the pathogenesis of influenza, RSV disease

12:00 - 13:45

Chairs 
Peter Openshaw
Katina Hulme

Experimental medicine studies of influenza, RSV disease and COVID-19

12:00 - 13:45

Chairs 
Christopher Chiu
Daniel Goldhill

Risk assessment and risk communication in acute respiratory virus infections

12:00 - 13:45

Chair 
Barbara Rath

Keynote lecture: Vaccine development and ensuring equitable acces to those most in need

12:00 - 12:30

Speaker 
Melanie Saville

“Long Covid”: post and acute clinical sequelae of COVID-19

12:00 - 13:45

Chair 
Susanne Herold

Strategies for future RSV disease vaccination

12:00 - 13:45

Chair 
Rebecca Cox
Live

Pandemic Preparedness Planning in Peacetime

12:00 - 13:45

Chair 
Ab Osterhaus
Live

Satellite Symposium organised by Sanofi Pasteur: INFLUENZA AND COVID-19 Burden of Disease and Prospects for Vaccination

14:00 - 15:45

Chair 
Ursula Kunze
Live

Satellite symposium organised by Roche: Impact of influenza antivirals in the post–COVID-19 era and preparing for the next pandemic

14:00 - 15:30

Chair 
Tristan Clark
Live

Satellite Symposium organised by Roche: Advancing COVID-19 treatment: current and future perspectives on antivirals

14:00 - 15:00

Chair 
Frederick G. Hayden
Live

Satellite Symposium organised by Janssen: Shining light on the spectrum of RSV disease burden in adults

14:00 - 15:45

Chair 
Peter Openshaw
Live

Satellite Symposium funded and organised by Seqirus: Influenza during COVID-19 and beyond: Challenges, Technologies and Strategies

16:00 - 17:45

Chair 
David Salisbury

Keynote lecture: Regulatory approvals in the US

16:00 - 16:30

Speaker 
Arnold Monto
Live

Poster Peek with Ab Osterhaus

16:00 - 17:00

Diagnostic testing in the management of acute respiratory infections in primary and secondary care

16:00 - 17:45

Chairs 
Michael Ison
Nicole Ngai Yung Tsang

Co-infections in influenza, RSV disease and COVID-19

16:00 - 17:45

Chair 
Barbara Rath

Keynote lecture: Next generation COVID-19 vaccines

16:30 - 17:00

Speaker 
Florian Krammer
Live

Satellite Symposium organised by Sabin Vaccine Institute’s Influenzer Intiative: “The Influenza Vaccines R&D Roadmap: Framework for a Flu-Free Future”

16:00 - 17:30

Live

Novel and outstanding scientific discoveries: Late Breakers

16:00 - 17:45

Chair 
Sylvie van der Werf
Live

Opening Ceremony

18:00 - 19:00

Chairs 
Ab Osterhaus
Marco Goeijenbier
Colin Russell
Live

Satellite Symposium organised by AstraZeneca: Tackling COVID-19: Exploring the prophylaxis toolkit

18:00 - 19:30

Chair 
Flor Munoz

Keynote lecture: Viral and host factors in the transmission of influenza and Covid-19

18:00 - 18:30

Speaker 
Wendy Barclay

Antiviral and immune therapy for influenza, RSV disease and COVID-19

18:00 - 19:45

Chair 
Frederick G. Hayden

Strategies for future Influenza vaccination

18:00 - 19:45

Chairs 
Florian Krammer
Nicholas Wu
Live

Global health perspectives on acute respiratory virus disease and how to ensure equitable access

18:00 - 19:45

Chair 
Ann Moen

Keynote lecture: Antibodies against SARS-CoV-2: A Global Collaboration

18:30 - 19:00

Speaker 
Erica Ollmann Saphire
Live

Recap of the day with Ab Osterhaus and Colin Russell

18:00 - 18:30

Live

Closing Ceremony

18:30 - 19:00

Chairs 
Ab Osterhaus
Colin Russell
Marco Goeijenbier
Live

Farewell Concert: Otomachine

19:00 - 20:30

Replay of Webinar: Vaccination in a COVID-19 era

20:00 - 21:30

Live

Satellite Symposium organised by Pfizer: Evolving the Science of mRNA Vaccines: Helping to Protect Against COVID‐19 Today

20:00 - 21:45

Chair 
Shanti Pather

Replay of Webinar: RSV disease in a COVID-19 era

20:00 - 21:30

Replay of Webinar: Childhood Influenza vaccination and treatment in a COVID-19 era

22:00 - 23:30

Replay of Webinar: COVID-19 treatment and medication

22:00 - 23:30

Replay of Webinar: Flu and COVID-19 booster vaccinations: where do we go?

22:00 - 23:30

  FILTER